CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer.

Br J Cancer · 2016 · PMC4997538 · PMID 27490802

Europe PMC DOI

hedged sentence

0.0850

closest p · 1.7× alpha

0.0850

boldest claim

The sentences

a weak trendP =0.085so close (0.05 < p ≤ 0.1)

A weak trend was observed for CXCL9 and the two lymphocytic subsets ( Figure 3B ;CD3: r =0.418; P =0.085; CD56: r =0.314; P =0.236).

also in 1,404 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.